Citation: J. Heyn et H. Bigalke, ERYTHROCYTE-GHOSTS - A MODEL FOR TRANSLOCATION OF TETANUS TOXIN THROUGH CYTOPLASMIC MEMBRANES DEVOID OF RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 26-26
Citation: B. Rinkleff et al., QUANTIFICATION OF ACETAMINOPHEN IN SERUM BY THE TRIPYRIDYL-S-TRIAZINE-ASSAY, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 679-679
Authors:
GOSCHEL H
WOHLFARTH K
FREVERT J
DENGLER R
BIGALKE H
Citation: H. Goschel et al., BOTULINUM A TOXIN THERAPY - NEUTRALIZING AND NONNEUTRALIZING ANTIBODIES-THERAPEUTIC CONSEQUENCES, Experimental neurology, 147(1), 1997, pp. 96-102
Citation: G. Ahnerthilger et H. Bigalke, MOLECULAR ASPECTS OF TETANUS AND BOTULINUM NEUROTOXIN POISONING, Progress in neurobiology, 46(1), 1995, pp. 83-96
Authors:
ERDAL E
BARTELS F
BINSCHECK T
ERDMANN G
FREVERT J
KISTNER A
WELLER U
WEVER J
BIGALKE H
Citation: E. Erdal et al., PROCESSING OF TETANUS AND BOTULINUM-A NEUROTOXINS IN ISOLATED CHROMAFFIN CELLS, Naunyn-Schmiedeberg's archives of pharmacology, 351(1), 1995, pp. 67-78
Authors:
BINSCHECK T
BARTELS F
BERGEL H
BIGALKE H
YAMASAKI S
HAYASHI T
NIEMANN H
POHLNER J
Citation: T. Binscheck et al., IGA PROTEASE FROM NEISSERIA-GONORRHOEAE INHIBITS EXOCYTOSIS IN BOVINECHROMAFFIN CELLS LIKE TETANUS TOXIN, The Journal of biological chemistry, 270(4), 1995, pp. 1770-1774
Authors:
BARTELS F
BERGEL H
BIGALKE H
FREVERT J
HALPERN J
MIDDLEBROOK J
Citation: F. Bartels et al., SPECIFIC ANTIBODIES AGAINST THE ZN2-BINDING DOMAIN OF CLOSTRIDIAL NEUROTOXINS RESTORE EXOCYTOSIS IN CHROMAFFIN CELLS TREATED WITH TETANUS OR BOTULINUM A NEUROTOXIN(), The Journal of biological chemistry, 269(11), 1994, pp. 8122-8127